Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSE

Conditions: Central Serous Chorioretinopathy

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 26

Sponsor: University Hospital, Bordeaux

Location: France

Summary

MICROPULSE study aims to evaluate the efficacy of navigated microsecond laser (nMSL) for chronic central serous chorioretinopathy (CSCR).

Eligibility Criteria

Inclusion Criteria:18 years and oldervision complaints for more than 6 weekssubretinal fluid confirmed on OCTdiagnosis of CSCR confirmed by fluorescein and indocyanine green angiographySigned informed consentAffiliated or beneficiary of health insuranceExclusion Criteria:History of treatment of CSC with other modalities (PDT, eplerenone) in the past 3 monthsOther macular conditions : Age-related Macular Degeneration (AMD), polypoidal vasculopathy, choroidal neovascularizationCataract or opacities interfering with acquisition or treatmentMyopia> 6 diopterVisual acuity<20/200Treatment with steroids (per-os, inhaled or cutaneous) in the past 3 monthsIntra-vitreal injections of anti-VEGF (Vascular Endothelial Growth Factor) or steroids in the past 3 monthsHistory of allergy to fluorescein or indocyanineInability to agree to participate to the studyPregnant or breastfeeding womanPatient under legal protection

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05679180). StuddyBuddy aggregates publicly available trial information.